Table 2

Clinical data of present group of PSRA patients (n=41). Data are means (SEM), or numbers of patients (%)

Abbreviation usedGASNGASGUS
Patient number6728
Interval sore throat-arthritis (days)35 (45)25 (14)17 (14)
Antibiotic pretreatment1 (17%) 1 (14%) 18 (68%)
Arthritis (number (%))
 monoarticular3 (50%)2 (29%)6 (21%)
 oligoarticular1 (17%)4 (57%)12 (43%)
 polyarticular2 (33%)1 (14%)10 (36%)
Symmetrical joints disease3 (50%)1(14%)16 (57%)
Shoulder0 (0%)0 (0%)1 (4%)
Elbow2 (33%)3 (43%)7 (25%)
Wrist1 (17%)3 (43%)14 (50%)
MCP1 (17%)4 (57%)9 (32%)
PIP2 (33%)2 (29%)7 (25%)
Knee2 (33%)5 (71%)17 (61%)
Ankle5 (83%)3 (43%)13 (46%)
MTP1 (16%)1 (14%)4 (14%)
Extra-articular findings (number (%))
carditis2-150 000
 first degree AV block1 (17%)02 (7%)
 hepatitis1 (17%)02 (7%)
erythema2 (33%)09 (32%)
 nodosum2 (33%)05 (18%)
 multiforme004 (14%)
lobular panniculitis001 (4%)
Recovery (days)30 (16)80 (60)42 (40)
  • 2-150 Echocardiography was performed in two (33%) of GAS, one (14%) of NGAS, and three (11%) of GUS induced PSRA patients: all normal findings. Statistical group comparisons: GASv GUS: p<0.05; NGASv GUS: p<0.05; insignificant p values are not demonstrated.